Implanet S.A. (EPA:ALIMP)
0.3850
+0.0360 (10.32%)
Sep 29, 2025, 11:44 AM CET
Implanet Revenue
Implanet had revenue of 5.29M EUR in the half year ending December 31, 2024, with 35.06% growth. This brings the company's revenue in the last twelve months to 11.10M, up 52.11% year-over-year. In the year 2024, Implanet had annual revenue of 9.41M with 26.31% growth.
Revenue (ttm)
11.10M
Revenue Growth
+52.11%
P/S Ratio
3.95
Revenue / Employee
241.26K
Employees
46
Market Cap
43.83M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.41M | 1.96M | 26.31% |
Dec 31, 2023 | 7.45M | -581.00K | -7.24% |
Dec 31, 2022 | 8.03M | 1.89M | 30.75% |
Dec 31, 2021 | 6.14M | 2.25M | 57.76% |
Dec 31, 2020 | 3.89M | -3.52M | -47.46% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sanofi | 45.74B |
Sartorius Stedim Biotech | 2.90B |
bioMérieux | 4.12B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.76B |
ABIVAX Société Anonyme | 6.02M |
Virbac | 1.43B |